Results 151 to 160 of about 755,616 (163)
Some of the next articles are maybe not open access.

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

New England Journal of Medicine, 2001
Renaud Capdeville   +2 more
exaly  

Strategies Toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors

Pharmacology & Therapeutics, 1999
Pascal Furet, Peter Traxler
exaly  

Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: Which, When, for Whom?

Nature Reviews Clinical Oncology, 2017
Gianantonio Rosti   +2 more
exaly  

Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions Are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors

Journal of Thoracic Oncology, 2018
Sai-Hong Ignatius Ou   +2 more
exaly  

Regulation of the c-Abl and Bcr–Abl Tyrosine Kinases

Nature Reviews Molecular Cell Biology, 2004
Oliver Hantschel, Giulio Superti-Furga
exaly  

An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis

New England Journal of Medicine, 2010
Michael E Weinblatt, Mark C Genovese
exaly  

Tyrosine Kinase Inhibition and Grey Hair

Lancet, The, 2003
Eric Raymond   +2 more
exaly  

Home - About - Disclaimer - Privacy